FURTHER FURTHER READING
© The Financial Times Ltd 2014 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
David Rosenberg, chief economist and market strategist at Gluskin Sheff & Associates, has turned slightly bullish.
Unfortunately, this has come as an unpalatable shock to a few people. Read more
There has been a lot of attention recently on Herbalife’s Californian business, where the company has received some criticism from within the Latino community.
Herbalife says that this is unfair, and that it would be delighted to help its critics understand the opportunity it provides to its many keen salespeople. What it might consider is a field trip to Mexico, where its nutritional shakes and direct sales model appear to be wildly popular.
Just how popular? Read more
I am shining a harsh light into the murky world of corporate behaviour. Why should good companies be destroyed by short-term investors looking for a speculative killing, while their accomplices in the City make fat fees?
-Vince Cable, Secretary of State for Business, Innovation and Skills, 2010 Read more
This is likely to ruffle the feathers of certain City grandees and also a few well-known corporate financier types. Click to read:
Live markets commentary from FT.com
Brad DeLong asks (politely) why oh why can’t we have better QE weblogging, and then issues a challenge:
Toward the end of an otherwise very good think piece, the intelligent and thoughtful Cardiff Garcia mysteriously writes: “But the downsides to continued QE aren’t trivial either.”
Which makes me ask: what are the downsides to continued QE?
Click for the ECB’s official introduction to its year-long “supervisory risk assessment… asset quality review and a stress test” for 124 European banks (who are all listed)…